FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387267587> ?p ?o ?g. }

• W4387267587 abstract "Background New reports suggest that anti-inflammatory drugs are widely used to treat respiratory tract infections caused by SARS-CoV-2. Anti-inflammatory drugs were the most frequently used treatment for the COVID-19-related cytokine storm in China. However, the efficacy of anti-inflammatory drugs has yet to be systematically analyzed, and clinicians are often uncertain which class of anti-inflammatory drug is the most effective in treating patients with respiratory tract infections caused by SARS-CoV-2, especially those with severe disease. Methods From 1 October 2022, relevant studies were searched in the PubMed, Embase, Medline, Cochrane Library, and Web of Science databases. A total of 16,268 publications were retrieved and collated according to inclusion and exclusion criteria, and sensitivity analyses were performed using STATA 14 software. Publication bias was assessed using funnel plots and Egger’s test. Study quality was assessed using the PEDro scale, and the combined advantage ratio was expressed as a 95% confidence interval (CI). In total, 19 randomized controlled trials were included in the study. STATA 14 software was used for all random effects model analyses, and the results are expressed as relative risk ratios (RR) with 95% CI. Results Quantitative analyses were performed on 14,514 patients from 19 relevant randomized controlled clinical trials. Pooled estimates (RR = 0.59, 95% CI 0.44–0.80) revealed that the use of anti-inflammatory drugs resulted in a significant reduction in mortality in patients with respiratory tract infection caused by SARS-CoV-2 compared with controls, and methylprednisolone (RR = 0.14, 95% CI 0.03–0.56) was more effective than other anti-inflammatory drugs. Anti-inflammatory drugs were effective in reducing mortality in critically ill patients (RR = 0.67, 95% CI 0.45–0.98) compared with non-critically ill patients (RR = 0.50, 95% CI 0.34–0.76); however, more clinical evidence is needed to confirm these findings. Conclusion The use of anti-inflammatory drugs in patients with respiratory infections caused by SARS-CoV-2 reduces patient mortality, especially in severe cases. In individual studies, methylprednisolone was more effective than other drugs." @default.
• W4387267587 created "2023-10-03" @default.
• W4387267587 creator A5002094026 @default.
• W4387267587 creator A5032201780 @default.
• W4387267587 creator A5046950830 @default.
• W4387267587 creator A5054433231 @default.
• W4387267587 creator A5061657921 @default.
• W4387267587 creator A5081646363 @default.
• W4387267587 creator A5083481951 @default.
• W4387267587 creator A5083548222 @default.
• W4387267587 creator A5085995690 @default.
• W4387267587 date "2023-10-02" @default.
• W4387267587 modified "2023-10-03" @default.
• W4387267587 title "Effect of anti-inflammatory drugs on the storm of inflammatory factors in respiratory tract infection caused by SARS-CoV-2: an updated meta-analysis" @default.
• W4387267587 cites W3010377921 @default.
• W4387267587 cites W3012083138 @default.
• W4387267587 cites W3030136428 @default.
• W4387267587 cites W3081721922 @default.
• W4387267587 cites W3084906944 @default.
• W4387267587 cites W3086786425 @default.
• W4387267587 cites W3087214787 @default.
• W4387267587 cites W3093587072 @default.
• W4387267587 cites W3121693389 @default.
• W4387267587 cites W3128201757 @default.
• W4387267587 cites W3135226293 @default.
• W4387267587 cites W3135942249 @default.
• W4387267587 cites W3137388553 @default.
• W4387267587 cites W3164764041 @default.
• W4387267587 cites W3164932383 @default.
• W4387267587 cites W3165476331 @default.
• W4387267587 cites W3168415043 @default.
• W4387267587 cites W3172484127 @default.
• W4387267587 cites W3173557551 @default.
• W4387267587 cites W3175301529 @default.
• W4387267587 cites W3182899447 @default.
• W4387267587 cites W3188676168 @default.
• W4387267587 cites W3197085679 @default.
• W4387267587 cites W3198379317 @default.
• W4387267587 cites W3206064057 @default.
• W4387267587 cites W3213715446 @default.
• W4387267587 cites W3215330689 @default.
• W4387267587 cites W4210642183 @default.
• W4387267587 cites W4210699625 @default.
• W4387267587 cites W4214726967 @default.
• W4387267587 cites W4220869821 @default.
• W4387267587 cites W4286447736 @default.
• W4387267587 cites W4294215472 @default.
• W4387267587 cites W4294408710 @default.
• W4387267587 cites W4295227068 @default.
• W4387267587 doi "https://doi.org/10.3389/fpubh.2023.1198987" @default.
• W4387267587 hasPublicationYear "2023" @default.
• W4387267587 type Work @default.
• W4387267587 citedByCount "0" @default.
• W4387267587 crossrefType "journal-article" @default.
• W4387267587 hasAuthorship W4387267587A5002094026 @default.
• W4387267587 hasAuthorship W4387267587A5032201780 @default.
• W4387267587 hasAuthorship W4387267587A5046950830 @default.
• W4387267587 hasAuthorship W4387267587A5054433231 @default.
• W4387267587 hasAuthorship W4387267587A5061657921 @default.
• W4387267587 hasAuthorship W4387267587A5081646363 @default.
• W4387267587 hasAuthorship W4387267587A5083481951 @default.
• W4387267587 hasAuthorship W4387267587A5083548222 @default.
• W4387267587 hasAuthorship W4387267587A5085995690 @default.
• W4387267587 hasConcept C126322002 @default.
• W4387267587 hasConcept C168563851 @default.
• W4387267587 hasConcept C17744445 @default.
• W4387267587 hasConcept C199539241 @default.
• W4387267587 hasConcept C2776012195 @default.
• W4387267587 hasConcept C2776478404 @default.
• W4387267587 hasConcept C2779473830 @default.
• W4387267587 hasConcept C2780439572 @default.
• W4387267587 hasConcept C2780805593 @default.
• W4387267587 hasConcept C44249647 @default.
• W4387267587 hasConcept C534529494 @default.
• W4387267587 hasConcept C535046627 @default.
• W4387267587 hasConcept C71924100 @default.
• W4387267587 hasConcept C82789193 @default.
• W4387267587 hasConcept C95190672 @default.
• W4387267587 hasConceptScore W4387267587C126322002 @default.
• W4387267587 hasConceptScore W4387267587C168563851 @default.
• W4387267587 hasConceptScore W4387267587C17744445 @default.
• W4387267587 hasConceptScore W4387267587C199539241 @default.
• W4387267587 hasConceptScore W4387267587C2776012195 @default.
• W4387267587 hasConceptScore W4387267587C2776478404 @default.
• W4387267587 hasConceptScore W4387267587C2779473830 @default.
• W4387267587 hasConceptScore W4387267587C2780439572 @default.
• W4387267587 hasConceptScore W4387267587C2780805593 @default.
• W4387267587 hasConceptScore W4387267587C44249647 @default.
• W4387267587 hasConceptScore W4387267587C534529494 @default.
• W4387267587 hasConceptScore W4387267587C535046627 @default.
• W4387267587 hasConceptScore W4387267587C71924100 @default.
• W4387267587 hasConceptScore W4387267587C82789193 @default.
• W4387267587 hasConceptScore W4387267587C95190672 @default.
• W4387267587 hasLocation W43872675871 @default.
• W4387267587 hasOpenAccess W4387267587 @default.
• W4387267587 hasPrimaryLocation W43872675871 @default.
• W4387267587 hasRelatedWork W1967911880 @default.
• W4387267587 hasRelatedWork W2014943083 @default.
• W4387267587 hasRelatedWork W2217553306 @default.
• W4387267587 hasRelatedWork W2792791170 @default.

• next